Slide 1: Welcome Investors August 2025
Welcome Investors March 2022 Welcome Investors August 2025
Slide 2: Forward Looking Statements
Forward Looking Statements 2 Certain statements in this presentation may be considered “forward - looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward - looking statements generally relate to future events
Slide 3: Who We Are
Who We Are UFP Technologies is a contract development and manufacturing organization (CDMO) that specializes in single use polymer based, medical devices 3 Ticker: UFPT Headquarters: Newburyport, MA Annual Revenue: ~$ 600 million 1 ~4,000 + Associates/ Temps Established: 1963 20 Manufacturing Facili
Slide 4: Helping customers get medical devices to market
We help our customers get their medical devices to market by offering expertise in design, materials, and global manufacturing locations 4 Design & engineering capabilities Materials expertise Strategic locations Precision manufacturing Shaping Innovation
Slide 5: Our Process
Our Process Innovative process from design and engineering to manufacturing and delivery 5
Slide 6: Product Development Business
Product Development Business 6 We bring deep experience in flexible material - based device manufacturing, from components and packaging, to final device assembly High Margin Added Expertise Stronger Customer Relationships Long Term Manufacturing 1 2 3 4 BENEFITS
Slide 7: MedTech Portfolio
MedTech Portfolio Robotic Drapes Revascularization Device Needleless Injection Port Cleaner MedSurg Bed Negative Pressure Wound Therapy Patient Safety 7
Slide 8: Global Medical Device Market, 6.3% CAGR
$518 billion, 6.3% CAGR 1 Global Medical Device Market Customers include 26 of the top 30 largest medical device manufacturers in the world 2 1. Fortune Business Insights - $518 billion as of 2023. 6.3% CAGR for a forecast period of 2024 - 2032. 2. Medical Design & Outsourcing 2024 MedTech Big 100.
Slide 9: Medical Segment Overview
Medical Segment Overview $518 Billion Global Device Market, 6.3% CAGR 1 Therapeutic Area % of Medical Sales 2 1 Fortune Business Insights - $518 billion as of 2023. 6.3% CAGR for a forecast period of 2024 - 2032. 2 Annual mix of revenue through June, 2025 Market Growth Mid Teens 29% Robotic Surgery
Slide 10: Surrounding a High-Growth End Market: Robotic Surgery
Surrounding a High - Growth End Market: Robotic Surgery 1 Surgical Robotics Market: Growth, Size, Share, and Trends Markets and MarketsTM August 2024 2 NIH 310 Million major surgeries performed each year: Geoffrey P Dobson 3 Towards Healthcare: Robotic Surgery Market Sizing • Market Size : ~$11B (20
Slide 11: Growth Strategy
Growth Strategy 11 Internal Growth: Market To Our Sweet Spot Strategic Acquisitions TWO - PRONGED
Slide 12: Organic Growth Opportunity
12 Organic Growth Opportunity Focus on high growth niche segments (MedTech – approximately 92% of revenue and growing) » Single - use, single - patient » Customer funded development Market to our sweet spot and differentiated capabilities » Leverage technology differentiation » Engineering resources
Slide 13: Acquisition Growth Opportunity
13 Acquisition Growth Opportunity Continue to Focus on Higher - Growth, Higher - Margin MedTech Opportunities that Create Value » Become more valuable to our customers » Strategic focus – new capability, geography, growing market segment, materials » Add scale » Look for synergistic opportunities »
Slide 14: Proven Acquisition Integration Model
0 100,000,000 200,000,000 300,000,000 400,000,000 500,000,000 600,000,000 700,000,000 2021 2022 2023 2024 2025 (TTM) MedTech Sales Over Time MedTech Sales Total Company Sales Proven Acquisition Integration Model Executing Strategy – Transformed from diversified industrial to differentiated MedTech $
Slide 15: Why Invest?
Why Invest? 15 Significant market growth opportunities Barriers to entry Strong customer relationships Experienced management team Proven growth strategy Attractive financial metrics
Slide 16: Significant Market Growth Opportunities
16 Significant Market Growth Opportunities Market Focused On » Better Patient Outcomes » Infection Prevention » Reducing Healthcare Costs Global Footprint » Bringing New Opportunities Focused on fast growing segments
Slide 17: Competitive Advantage
Competitive Advantage » Advanced systems (extensive quality certifications) » In addition to existing equipment, engineers will design product specific innovations in order to meet customer needs Quality & Regulatory » In - house custom equipment manufacturing capabilities Custom Equipment » Numerou
Slide 18: Proven Growth Strategy Creating Shareholder Value
Proven Growth Strategy 18 Creating Shareholder Value
Slide 19: Financial Targets
Financial Targets 19
Slide 20: Financial Targets
Financial Targets 20 3 to 5 Year Financial Targets 12 - 18% Revenue Growth 28 - 31% Gross Margin 17 - 20% Adjusted Operating Margin
Slide 21: 12% to 18% Targeted Revenue Growth
12% to 18% Targeted Revenue Growth Internal Growth + Acquisitions $0 $100 $200 $300 $400 $500 $600 $700 2020 2021 2022 2023 2024 June 2025 TTM 21 Revenue TTM = 12 - month period ended June 30, 2025
Slide 22: Gross Margin Target – 28% to 31%
Gross Margin Target – 28% to 31% Operating Leverage from Mix Shift + Acquisition synergies + Efficiencies 22 Gross Profit Margin Target: 28 - 31% 24.9% 24.8% 25.5% 28.1% 29.1% 28.6% 18.0% 20.0% 22.0% 24.0% 26.0% 28.0% 30.0% 32.0% 2020 2021 2022 2023 2024 Q2 YTD
Slide 23: Adjusted Operating Margin Target – 17% to 20%
Adjusted Operating Margin Target - 17% to 20% Operating leverage from mix shift + acquisition synergies + efficiencies 23 Adjusted* Operating Margin Target: 17 - 20% *See non - GAAP reconciliation on slide 32 10.3% 11.1% 13.8% 16.4% 18.3% 17.7% 0.0% 5.0% 10.0% 15.0% 20.0% 2020 2021 2022 2023 2024 Q2
Slide 24: UFP Historical Stock Performance
UFP Historical Stock Performance 20 Years 24 *Measured as the percent increase from August 5 , 2005 through August 5, 2025 0% 1000% 2000% 3000% 4000% 5000% 6000% 7000% 8000% 9000% 10000% 11000% UFP Technologies (UFPT) Price % Change Russell 2000 (RUT) Price % Change S&P 500 (SPX) Price % Change 6496
Slide 25: Mitch Rock President Newburyport, Massachusetts Ron Lataille CFO, Sr. VP & Treasurer Newburyport, Massachusetts
Mitch Rock President Newburyport, Massachusetts Ron Lataille CFO, Sr. VP & Treasurer Newburyport, Massachusetts UFP Technologies 100 Hale St. Newburyport, MA 01950 978 - 352 - 2200 investorinfo@ufpt.com www.ufpt.com
Slide 26: Reconciliation of Non-GAAP Results
Appendix Reconciliation of Non - GAAP Results 26 (in Millions) 2020 2021 2022 2023 2024 Q2 2025 Revenue, As Reported $ 179.4 $ 206.3 $ 353.8 $ 400.1 $ 504.4 $ 299.3 Operating Income, as Reported 16.7 21.2 55.4 57.7 80.9 47.5 Add: Purchase Accounting Expenses - - - - 1.1 - Add: Acquisition Related Co